Description

The HPV vaccine (such as Gardasil 9) is a highly effective, safe vaccine that prevents infections causing most cervical, anal, and genital cancers, as well as warts. Recommended for ages 9–26, it is most effective when given before sexual activity. It requires 2–3 doses, with adults up to 45 able to receive it. Mayo Clinic Mayo Clinic +4 Key Details About the HPV Vaccine Who Should Get It: The CDC recommends vaccination for children at age 11 or 12, but it can start at age 9. Catch-up vaccination is recommended for everyone through age 26. Adults aged 27–45 should discuss with their provider if they might benefit. Dosage Schedule: Age 9–14: Two doses, with the second dose given 6–12 months after the first. Age 15–45: Three doses, usually given over six months. Effectiveness & Protection: The vaccine offers >99% protection against specific HPV strains it covers (e.g., HPV types 16 and 18, which cause most cervical cancers). It protects against anal, vulvar, vaginal, and oropharyngeal cancers. Safety & Side Effects: The vaccine is safe, with the most common side effects being mild, such as pain, swelling, or redness at the injection site. Important Considerations: The vaccine is not recommended during pregnancy. It does not treat existing HPV infections or HPV-related diseases. Availability (India context): In India, options like CERVAVAC and Gardasil are used, often in government campaigns for girls aged 9–14.